Erratum: A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis(Modern Rheumatology DOI: 10.1007/s10165-011-0574-9);A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis

Modern Rheumatology

Volumn 22, Issue 5, 2012, Pages 695-703

  Peng, Wen Jia ^a   Pan, Hai Feng ^a   Tao, Jin Hui ^b   Wang, Bing Xiang ^a   Lu, Man Man ^a   Wang, Song ^a   He, Qian ^a   Wang, Jing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

ACE; CTLA 4; Meta analysis; Polymorphism; STAT4; Systemic sclerosis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL CARBOXYPEPTIDASE; STAT4 PROTEIN;

CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; PUBLISHING; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS;

EID: 84870387120     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0671-4     Document Type: Erratum

References (41)

1. Nietert PJ, Silver RM. Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol. 2000;12:520-6.
2. Randone SB, Guiducci S, Cerinic MM. Systemic sclerosis and infections. Autoimmun Rev. 2008;8:36-40.
3. Valentini G, Black C. Systemic sclerosis. Best Pract Res Clin Rheumatol. 2002;16:807-16.
4. Coral-Alvarado P, Pardo AL, Castano-Rodriguez N, Rojas-Villarraga A, Anaya JM. Systemic sclerosis: a world wide global analysis. Clin Rheumatol. 2009;28:757-65.
5. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37:223-35.
6. Tan FK. Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin N Am. 2003;29:211-37.
7. McCormic ZD, Khuder SS, Aryal BK. Occupational silica exposure as a risk factor for scleroderma: a meta-Analysis. Int Arch Occup Environ Health. 2010;83:763-9.
8. Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Tolédano C, Fabre B, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a meta-Analysis of case-control studies. J Rheumatol. 2007;34:97-103.
9. Harper K, Balzano C, Rouvier E, Mattéi MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol. 1991;147:1037-44.
10. Aguilar F, Torres B, Sánchez-Román J, Núnez- Roldán A, Gonza ́lez-Escribano MF. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol. 2003;64:936-40.
11. Vaidya B, Pearce SH, Charlton S, Marshall N, Rowan AD, Griffiths ID, et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford). 2002;41:180-3.
12. Ligers A, Xu C, Saarinen S, Hillert J, Olerup O. The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol. 1999;97:182-90.
13. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80: 41-5.
14. Kaufman KM, Kelly J, Gray-McGuire C, Asundi N, Yu H, Reid J, Baird T, et al. Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol. 2001;177:81-5.
15. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-6.
17. Fatini C, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, et al. High prevalence of polymorphisms of angiotensinconverting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med. 2002;112:540-4.
18. Assassi S, Mayes MD, McNearney T, Fischbach M, Reveille JD, Arnett FC, et al. Polymorphisms of endothelial nitric oxide synthase and angiotensin- converting enzyme in systemic sclerosis. Am J Med. 2005;118:907-11.
19. Lim CP, Cao X. Structure, function, and regulation of STAT proteins. Mol Biosyst. 2006;2:536-50.
20. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev. 2004;202:139-56.
21. Yuan H, Feng JB, Pan HF, Qiu LX, Li LH, Zhang N, et al. A meta-Analysis of the association of STAT4 polymorphism with systemic lupus erythematosus. Mod Rheumatol. 2010;20:257-62.
22. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357:977-86.
23. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-2.
24. Banerjee I. Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-Analysis. Eur J Epidemiol. 2010;25:449-58.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
26. EggerM, Davey SG, Schneider M, Minder C. Bias in meta-Analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
27. Hudson LL, Silver RM, Pandey JP. Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis. J Rheumatol. 2004;31:85-7.
28. Rueda B, Broen J, Simeon C, Hesselstrand R, Diaz B, Suarez H, et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet. 2009;18:2071-7.
29. Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes Immun. 2006;7:401-6.
30. Balbi G, Ferrera F, Rizzi M, Piccioli P, Morabito A, Cardamone L, et al. Association of -318 C/T and ?49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin Exp Immunol. 2007;149:40-7.
31. Rajaee A, Ebrahimi A, Ghiam AF, Kalantari T, Ghaderi A. Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients. Rheumatol Int. 2006;26:687-92.
32. Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K. Association of CTLA-4 with systemic sclerosis in Japanese patients. Clin Exp Rheumatol. 2002;20:823-8.
33. Joung CI, Park YW, Kim SK, Uhm WS, Kim TH, Yoo DH. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Korean patients with systemic sclerosis. J Korean Med Sci. 2006;21:329-32.
34. Bartoli F, Angotti C, Fatini C, Conforti ML, Guiducci S, Blagojevic J, et al. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford). 2007;46:772-5.
35. Guiducci S, Fatini C, Georgountzos A, Sticchi E, Cinelli M, Kaloudi O, et al. Etrurians vs Greeks: may ACE I/D polymorphism still be considered as a marker of susceptibility to SSc? Clin Exp Rheumatol. 2006;24:432-4.
36. Wipff J, Gallier G, Dieude P, Avouac J, Tiev K, Hachulla E, et al. Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians. J Rheumatol. 2009;36:337-40.
37. Dieudé P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E, et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum. 2009;60:2472-9.
38. Tsuchiya N, Kawasaki A, Hasegawa M, Fujimoto M, Takehara K, Kawaguchi Y, et al. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann Rheum Dis. 2009;68:1375-6.
39. Kaplan MH. STAT4: a critical regulator of inflammation in vivo. Immunol Res. 2005;31:231-42.
40. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010;42:426-9.
41. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol. 2006;163: 300-9.